Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP182116.RAxq-qZGxCm-skDvAH1bCbLR5FSslZem3x_MH1kN-KGbk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP182116.RAxq-qZGxCm-skDvAH1bCbLR5FSslZem3x_MH1kN-KGbk130_assertion type Assertion NP182116.RAxq-qZGxCm-skDvAH1bCbLR5FSslZem3x_MH1kN-KGbk130_head.
- NP182116.RAxq-qZGxCm-skDvAH1bCbLR5FSslZem3x_MH1kN-KGbk130_assertion description "[Mutations of the KRAS, BRAF, and PIK3CA genes have been reported in colorectal cancer (CRC), associated with resistance to epidermal growth factor receptor (EGFR)-targeted monoclonal antibody therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP182116.RAxq-qZGxCm-skDvAH1bCbLR5FSslZem3x_MH1kN-KGbk130_provenance.
- NP182116.RAxq-qZGxCm-skDvAH1bCbLR5FSslZem3x_MH1kN-KGbk130_assertion evidence source_evidence_literature NP182116.RAxq-qZGxCm-skDvAH1bCbLR5FSslZem3x_MH1kN-KGbk130_provenance.
- NP182116.RAxq-qZGxCm-skDvAH1bCbLR5FSslZem3x_MH1kN-KGbk130_assertion SIO_000772 20652941 NP182116.RAxq-qZGxCm-skDvAH1bCbLR5FSslZem3x_MH1kN-KGbk130_provenance.
- NP182116.RAxq-qZGxCm-skDvAH1bCbLR5FSslZem3x_MH1kN-KGbk130_assertion wasDerivedFrom gad-20150221 NP182116.RAxq-qZGxCm-skDvAH1bCbLR5FSslZem3x_MH1kN-KGbk130_provenance.
- NP182116.RAxq-qZGxCm-skDvAH1bCbLR5FSslZem3x_MH1kN-KGbk130_assertion wasGeneratedBy ECO_0000203 NP182116.RAxq-qZGxCm-skDvAH1bCbLR5FSslZem3x_MH1kN-KGbk130_provenance.